Semaglutide
Premium GLP-1 receptor agonist API for next-generation diabetes and obesity therapeutics. Engineered for superior glycemic control with sustained weight reduction benefits. FDA-compliant manufacturing with ≥99% HPLC purity. One-stop CRDMO services available.
Exclusively tailored peptide API for Shenzhen Zhaoke, produced with 28 years of focus on peptide innovation. As a high-purity GLP-1 receptor agonist, it focuses on the metabolic disease field, relying on AI intelligent drug technology and the entire industrial chain advantage to provide core raw materials for Shenzhen Zhaoke’s innovative formulation R&D and help expand the global metabolic drug market.
| CAS | 910463-68-2 |
| Molecular Formula | C₁₈₇H₂₉₁N₄₅O₅₉ |
| Molecular Weight | 4113.64 g/mol |
| Category | GLP-1 & Incretin Metabolic Peptides |
| Purity | >=99% (HPLC) |
| Status | GMP-compliant, FDA-ready |
| Applications | Type 2 diabetes, obesity management, cardiovascular risk reduction |
| CAS | 910463-68-2 |
|---|---|
| Applications | cardiovascular risk reduction, obesity management, Type 2 diabetes |
Related products
-
Mazdutide
CAS: 2259884-03-0Applications: metabolic syndrome, Overweight treatment, Type 2 diabetes -
Dulaglutide
CAS: 923950-08-7 -
Retatrutide
CAS: 2381089-83-2Applications: Refractory diabetes, Severe obesity, Triple agonist, weight management -
Liraglutide
CAS: 204656-20-2Applications: cardiovascular risk reduction, GLP-1, obesity management